300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
CHANEL, VC Fund

CHANEL

VC Fund

Neuilly-sur-seine, France

CHANEL is a VC fund in Neuilly-sur-seine focused on Biotechnology and Beauty. CHANEL is above all a style. Fashion passes, style remains."​ Gabrielle Chanel This simple statement captures the essence of her revolutionary contribution to culture. Designer, visionary, artist, Gabrielle ‘Coco’ Chanel reinvented fashion by transcending its conventions, creating an uncomplicated luxury that changed women’s lives forever. She followed no rules, epitomizing the very modern values of freedom, passion and feminine elegance. CHANEL continues, after almost a century, to inspire women of all ages all over the world with its timeless modernity. CHANEL has continued this glorious heritage of creation, playing fearlessly with Coco’s radical legacy, offering a vision for the future of the House that is as memorable as its past.

Total investments:
15
Last investment:
Lead investor:
27%

Last updated:

Industries CHANEL invests in

BiotechnologyBeautyChemicalCosmeticsConsumer Goods

Stages CHANEL invests in

Funding RoundVenture - Series UnknownSeries CCorporate RoundSeed

Countries CHANEL invests in

United StatesSwitzerlandFranceTaiwanFinland

Round sizes

Series C $12M–$120M

Contacts

NameEmailPhoneSocials
See all 8 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series C
$12M–$120M

Investment Focus

Industry

  • Biotechnology 3 (20%)
  • Beauty 2 (13%)
  • Chemical 2 (13%)
  • Cosmetics 2 (13%)
  • Consumer Goods 2 (13%)
See all 22 industries →

Stage

  • Funding Round 3 (20%)
  • Venture - Series Unknown 3 (20%)
  • Series C 2 (13%)
  • Corporate Round 2 (13%)
  • Seed 1 (7%)
See all 8 stages →

Country

  • United States 4 (27%)
  • Switzerland 2 (13%)
  • France 1 (7%)
  • Taiwan 1 (7%)
  • Finland 1 (7%)

Team

NameTitleInvestmentsLinksEmail
Adina Kagan
Adina Kagan SVP, Media & Insights
SVP, Media & Insights Total investments: 0
Find email
Inna Lahancika
Inna Lahancika Financial Controller for Scandinavia
Financial Controller for Scandinavia Total investments: 0
Find email
Laurence Perrin
Laurence Perrin Chief Compliance Officer
Chief Compliance Officer Total investments: 0
Find email
Nick Hochland Chief Executive Officer
Chief Executive Officer Total investments: 0 Find email
Philippe Blondiaux
Philippe Blondiaux Global C.F.O.
Global C.F.O. Total investments: 0
Find email
See all 8 team members →

Investments

CompanyDescriptionRoundLinks
EBEL is an e-commerce company that manufactures watches. Oct 08, 2026
P2 Science a venture-backed, renewable specialty chemicals company, co-founded by Yale scientists, a chemical industry CEO and Elm Street Ventures, an early-stage venture fund. P2 Science has developed a unique process technology for converting renewable feedstocks—including vegetable oils—into high-value, specialty chemicals. These includeflavor, fragrance and cosmetics ingredients. Many of their products are today available only from petrochemical sources. Among the first products to be produced by P2 are vegetable-derived, cost-effective versions of current petrochemical fragrance ingredients. Major users and formulators of specialty chemicals have a strong interest in substituting renewable for petrochemical ingredients. Patrick Foley, a Yale graduate of the PhD program in Environmental Engineering, is P2′s Chief Scientific Officer. Neil Burns, an executive with 20+ years experience in the specialty chemical industry, is the company’s CEO. P2 has a laboratory in New Haven, CT to support this technology’s development and commercialization, as well as partnerships with major companies at a number of points along the supply chain. $23M / May 26, 2026
MB&F M.A.D.Gallery is a captivating universe of kinetic art where horological machines and mechanical art devices reign supreme. MB&F is a creative laboratory that crafts three dimensional horological machines.MB&F (Maximilian Busser & Friends) was founded in 2005 by Maximilian Busser. By harnessing the power of the Friends,which are dedicated collectives of the top independent artisans and watchmakers in Switzerland, MB&F creates contemporary time-telling mechanical sculptures.Each MB&F Horological Machine represents the best of the best in the world of watches. By giving full credit to the all star team creating each Machine, the pieces become a showpiece for the most cutting edge designs, the best finishing, the integration of new technologies, in all the highest quality possible. Corporate Round / Aug 22, 2024
Co-created in July 2016 by Justine LIPUMA, PhD in microbiology, and Christine PONCET-DOISE, Senior Research Engineer at INRA, MYCOPHYTO is the result of 30 years of experimentation in biological crop protection. $5.4M / Seed / Jun 01, 2024
P2 Science a venture-backed, renewable specialty chemicals company, co-founded by Yale scientists, a chemical industry CEO and Elm Street Ventures, an early-stage venture fund. P2 Science has developed a unique process technology for converting renewable feedstocks—including vegetable oils—into high-value, specialty chemicals. These includeflavor, fragrance and cosmetics ingredients. Many of their products are today available only from petrochemical sources. Among the first products to be produced by P2 are vegetable-derived, cost-effective versions of current petrochemical fragrance ingredients. Major users and formulators of specialty chemicals have a strong interest in substituting renewable for petrochemical ingredients. Patrick Foley, a Yale graduate of the PhD program in Environmental Engineering, is P2′s Chief Scientific Officer. Neil Burns, an executive with 20+ years experience in the specialty chemical industry, is the company’s CEO. P2 has a laboratory in New Haven, CT to support this technology’s development and commercialization, as well as partnerships with major companies at a number of points along the supply chain. Venture - Series Unknown / Feb 23, 2023
Yangi Yangi
Yangi is a provider of environmentally friendly packaging solutions. Venture - Series Unknown / Jan 24, 2023
Perfect Corp. is dedicated to transforming how consumers, content creators and beauty brands interact together. Their unique platform is the premier online destination for all beauty lovers. Their apps, YouCam Makeup, recently voted Best Fashion & Apparels App* of 2015, and market-leading YouCam Perfect redefine virtual beauty for tens ofmillions of users. Their experienced team of engineers and beauty aficionados is pushing the frontiers of technology to create the beauty platform of the future – a fluid environment where individuals express themselves, learn the latest about fashion and beauty, and enjoy instant access to the products from their favorite brands.*YouCam Makeup is the winner of 2015 Appy Award of Best Fashion & Apparels App. $105M / Post-IPO Equity / Oct 28, 2022
Evolved by Nature, based in Boston, was started by biomedical engineer Rebecca Lacouture and chemist Gregory Altman in 2013. Their product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company has patented dozens of molecular combinations of the natural silk protein since filing its firstapplication in 2014. $120M / Series C / Jun 30, 2022
Evolved by Nature, based in Boston, was started by biomedical engineer Rebecca Lacouture and chemist Gregory Altman in 2013. Their product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company has patented dozens of molecular combinations of the natural silk protein since filing its firstapplication in 2014. $70M / Series B / Dec 24, 2021
Arcaea mission to build a new foundation for the beauty industry through expressive biology. Arcaea sees biology as a valuable creative tool for self expression. The company will grow new ingredients and product experiences for beauty through technology such as DNA sequencing, biological engineering, fermentation and more. $78M / Series A / Oct 27, 2021
See all 15 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does CHANEL invest in?

CHANEL invests primarily in Biotechnology, Beauty and Chemical startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does CHANEL invest in?

CHANEL typically joins rounds of $12M–$120M at Series C. These are whole funding-round sizes, not CHANEL's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds CHANEL took part in.

How do I contact CHANEL?

Public channels for CHANEL include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at CHANEL?

The team at CHANEL includes Adina Kagan (SVP, Media & Insights), Inna Lahancika (Financial Controller for Scandinavia) and Laurence Perrin (Chief Compliance Officer), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
CHANEL CHANEL Find emails